Cells/cancer Flashcards
Tumor
Benign or malignant
Neoplasm
Global term for mass may be malignant or benign
Benign tumor
Non-cancerous growth
Malignant tumor
Cancerous
Cancer
Any malignant growth or tumor caused by an abnormal division of cells
Features of a benign tumor
Slow growth
well-defined capsule
non-invasive
Well differentiated
Low mitotic index
Does not metastasize
Features of a malignant tumor
Rapid growth
Not encapsulated
Invasive
Poorly differentiated anaplastic
High mitotic index
Can spread distantly by metastasis
Cancer cells versus normal cells
Cancer cells do not follow usual cellular control mechanisms, no contact inhibition don’t need a anchor they can grow in suspension and have a long lifespan
They lack differentiation (anaplasia) do not acquire specialized function or organization cells are pleomorphic size and shape is not uniform non-differentiated more malignant
Metabolism divide rapidly able to survive and sub optimal environments where normal cells would die. Use nutrients so none are available for normal cells. Can perform glycolysis without using mitochondria to generate usual ATP but still generate normal numbers of ATP molecules. Despite using anaerobic metabolic pathways, they are able to form lipids and other cellular building blocks or normal cells cannot do this.
Stem cells, normal cells, regenerate, using adults stem cells whereas cancer cells are heterogeneous using cancer, stem cells
Cancer formation
DNA is damaged cell fail to repair activation or growth promoting on genes and inactivation of tumor, suppressing genes results and unregulated cell proliferation alteration in genes that regulate apoptosis clonal expansion (angiogenesis, cells elude immune system and continue to mutate) cells, progressive, tumor, malignancy, or metastasis
-Oma
Tumor or cancer
Carcinoma
Arising from epithelial tissue
Sarcoma
Arising from mesenchymal tissue
Adenocarcinoma
Airing from ducts or glands
Leukemia
Cancer of blood forming cells
Lymphoma
Cancer of lymphatic tissue
Blastomas
Malignancy in precursor cells or blasts common in children
Carcinoma in Situ
Original place has not spread a pre-invasive cancer atypical cells may not have penetrated the basement membrane of the organ no local invasion, but has potential to remain where it is and not change or progress to invade in metastasize or regress and go away the more dysplastic, the more likely it is to be invasive
Oncogenes
Oncogenes are mutated or over-express proto-oncogenes (genes encode components of receptor mediated pathways designed to regular normal cellular proliferation) which are independent of normal regulatory mechanisms they may amplify make numerous copies of mutated genes. This is important for both prognosis and therapy.
Role of inflammatory suppression and cancer
Tumor, suppressing genes (antioncogenes) inhibit or decelerate cellular proliferation suppress oncogenes decrease cellular, growth, mutation, and replication
Role of inflammatory progression, and cancer
Cancer cells use the inflammatory response to their benefit, using the healing and proliferation pathways to support growth and progression. They have the ability to produce chemotactic signals, attracting macrophages producing mediators, decreasing inflammation, increasing proliferation, and angiogenesis
Macrophages decreases toxic response do not kill the cancer cells
T regulatory self change there is no cancer cell destruction. There is production of cytokines lead into cancer, cell proliferation, and spread.
Paraneoplastic syndrome
Rare sometimes the first symptom that there is cancer present, cause not by the cancer itself, but by the inflammatory response caused by the cancer or worsen by the cancer may be life-threatening includes Cushing’s disease syndrome of inappropriate anti-diuretic hormone, hypercalcemia hypoglycemia, polycythemia osteomalacia myasthenia disorders of the central nervous system or peripheral nervous system, acanthosis nigricans, dermatomyositis, hypertrophic osteoarthropathy and clubbing of the fingers Venous thrombosis (trousseau phenomenon) DIC, non-bacterial thrombotic, endocarditis, red cell aplasia nephrotic syndrome
Cachexia
Complex metabolic syndrome associated with muscle loss with or without fat loss in cancer in involves systemic, inflammation negative protein and energy, balance and loss of lean muscle mass again with or without wasting of adipose occurs in 50 to 80% of individuals with cancer implicated in 20% of death related to cancer
Mechanisms include anorexia, decrease secretions of anabolic hormones altered metabolic response with abnormal protein, lipid and carb metabolism. It appears the mitochondria and sarcoplasm reticulum have a role.
Alpha fetoprotein tumor marker
Liver and germs cell tumors
Prostate specific antigen
Prostate CA